Basilea Pharmaceutica International Ltd
Overview
Basilea Pharmaceutica International Ltd specializes in developing innovative medicines to meet the needs of patients with infectious diseases and cancer. The company focuses on the research, development, and commercialization of pharmaceutical products to address areas of high medical need.
Therapeutic areas
API / Drug Master Files
Basilea Pharmaceutica International Ltd holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CEFTOBIPROLE MEDOCARIL (R473928) DRUG SUBSTANCEInactive2007-05-03
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Basilea Pharmaceutica International Ltd in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.